1-86348823-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001366781.1(ODF2L):c.1862C>T(p.Ser621Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000443 in 1,558,796 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000086 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000040 ( 1 hom. )
Consequence
ODF2L
NM_001366781.1 missense
NM_001366781.1 missense
Scores
4
4
8
Clinical Significance
Conservation
PhyloP100: 7.69
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.18054846).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ODF2L | NM_001366781.1 | c.1862C>T | p.Ser621Leu | missense_variant | 17/17 | ENST00000460698.7 | NP_001353710.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000857 AC: 13AN: 151746Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
13
AN:
151746
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000478 AC: 10AN: 209008Hom.: 0 AF XY: 0.0000527 AC XY: 6AN XY: 113892
GnomAD3 exomes
AF:
AC:
10
AN:
209008
Hom.:
AF XY:
AC XY:
6
AN XY:
113892
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000398 AC: 56AN: 1406934Hom.: 1 Cov.: 30 AF XY: 0.0000530 AC XY: 37AN XY: 697666
GnomAD4 exome
AF:
AC:
56
AN:
1406934
Hom.:
Cov.:
30
AF XY:
AC XY:
37
AN XY:
697666
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000856 AC: 13AN: 151862Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 5AN XY: 74202
GnomAD4 genome
AF:
AC:
13
AN:
151862
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
74202
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
7
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.1790C>T (p.S597L) alteration is located in exon 17 (coding exon 16) of the ODF2L gene. This alteration results from a C to T substitution at nucleotide position 1790, causing the serine (S) at amino acid position 597 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Vest4
0.81
MVP
ClinPred
T
GERP RS
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at